About the job
Role Summary This is an exciting opportunity to join the Pfizer Dermatology franchise within Specialty Care. Pfizer Dermatology has 2 on-market products and a new indication expected next year. LITFULO, launched in 2023, is an oral JAK inhibitor indicated for Alopecia Areata (AA). CIBINQO, launched in 2022, is an oral JAK inhibitor indicated for moderate-to-severe Atopic Dermatitis (AD). Pfizer Dermatology is seeking a franchise-level Regional Brand Activation Director. The Regional Brand Activation Director is a…
Members only
Read the full job and apply
Start your free 7 day trial to see the full description, the apply link and pay for every job. No card needed.